Results 211 to 220 of about 754,759 (237)
Some of the next articles are maybe not open access.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2006
Dengue is an expanding health problem. About two-fifths of the world population are at risk for acquiring dengue with 50-100 million cases of acute febrile illness yearly including about 500,000 cases of DHF/DSS. No antiviral drugs active against the flavivirus exist. Attempts to control mosquito vector has been largely unsuccessful.
Sriluck, Simasathien +1 more
openaire +1 more source
Dengue is an expanding health problem. About two-fifths of the world population are at risk for acquiring dengue with 50-100 million cases of acute febrile illness yearly including about 500,000 cases of DHF/DSS. No antiviral drugs active against the flavivirus exist. Attempts to control mosquito vector has been largely unsuccessful.
Sriluck, Simasathien +1 more
openaire +1 more source
The Lancet
Summary Dengue, caused by four closely related viruses (DENV-1–4), is a growing global public health concern, with outbreaks capable of overwhelming healthcare systems and disrupting economies.
Gabriela Paz-Bailey +4 more
semanticscholar +1 more source
Summary Dengue, caused by four closely related viruses (DENV-1–4), is a growing global public health concern, with outbreaks capable of overwhelming healthcare systems and disrupting economies.
Gabriela Paz-Bailey +4 more
semanticscholar +1 more source
Dengue vaccines: preparing to roll back dengue.
Current opinion in investigational drugs (London, England : 2000), 2003Dengue is an emerging viral pathogen of growing global importance, infecting up to 100 million people annually. Although there have been many efforts over the last six decades to produce a vaccine to combat this infection, few have been able to meet the challenges posed by the unusual interplay between this virus and its human host.
Jacobs, M., Young, P. R.
openaire +3 more sources
Nihon rinsho. Japanese journal of clinical medicine, 2011
Dengue fever is the most important mosquito-borne viral disease in the world, for which preventive vaccines are urgently required. Several strategies have been used for dengue tetravalent vaccine development. Strategies with traditional attenuation, chimerization, engineered attenuation are in the more advanced stages. In addition, inactivated, subunit,
openaire +1 more source
Dengue fever is the most important mosquito-borne viral disease in the world, for which preventive vaccines are urgently required. Several strategies have been used for dengue tetravalent vaccine development. Strategies with traditional attenuation, chimerization, engineered attenuation are in the more advanced stages. In addition, inactivated, subunit,
openaire +1 more source
TAK-003: development of a tetravalent dengue vaccine
Expert Review of VaccinesIntroduction Dengue incidence has increased over the past few decades. One tetravalent dengue vaccine based on a yellow fever backbone has been approved, but due to increased risk of severe disease in dengue-naïve recipients, its use is limited to ...
X. Sáez-llorens +7 more
semanticscholar +1 more source
New Vaccines on the Immediate Horizon for Travelers: Chikungunya and Dengue Vaccines
Current Infectious Disease Reports, 2023Wilder-Smith Annelies
exaly
Dengue vaccines: Are they safe for travelers?
Travel Medicine and Infectious Disease, 2016S. Halstead, M. Aguiar
semanticscholar +1 more source
Next generation dengue vaccines: A review of candidates in preclinical development
Vaccine, 2011John Roehrig +2 more
exaly